Browse Category

NASDAQ:XERS 30 July 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

Corcept Therapeutics (NASDAQ:CORT) surges 27% after Lifyorli boosts second-half expectations

Shares of Corcept Therapeutics Incorporated jumped 27.4% to $118.41 as of 13:45 EDT. The company reported a 32% increase in quarterly sales and lifted its full-year guidance.

30 July 2026

Earnings·NASDAQ:CORT·NASDAQ:XERS·Pharmaceuticals·Stock Market

#1 BUY ON PULLBACK

Microsoft

NASDAQ: MSFT 94 / 100

#2 BUY

L3Harris Technologies

NYSE: LHX 90 / 100

#3 BUY

Xylem

NYSE: XYL 89 / 100

#4 BUY IN TRANCHES

Lam Research

NASDAQ: LRCX 87 / 100

#5 BUY ON WEAKNESS

GE HealthCare

NASDAQ: GEHC 84 / 100

View full portfolio

Go toTop

NASDAQ:XERS 30 July 2026

Corcept Therapeutics (NASDAQ:CORT) surges 27% after Lifyorli boosts second-half expectations

Top Stock Picks

Microsoft

L3Harris Technologies

Xylem

Lam Research

GE HealthCare

Stock Market Today

Corcept Therapeutics (NASDAQ:CORT) surges 27% after Lifyorli boosts second-half expectations

Ondas (NASDAQ:ONDS) rises 9% after DZYNE issuance alters BlackRock (NYSE:BLK) ownership

Chipotle Mexican Grill (NYSE:CMG) Shares Rise 13% on Sales Rebound Despite Margin Pressure

Cycurion shares jump 400% after securing $54.6 million contract; funding remains immediate hurdle

Keel Infrastructure Corp. (NASDAQ:KEEL) surges 30% after BlackRock Inc. (NYSE:BLK) reveals 8.4% holding

Nuwellis (NASDAQ:NUWE) surges 130% as pediatric Aquadex update prompts heavy trading

SK hynix ADR Premium Approaches 60% Amid Continuing Selloff in Seoul

Alnylam Pharmaceuticals (NASDAQ:ALNY) drops 28% as company lowers Amvuttra outlook

Caterpillar (NYSE:CAT) Gains Following Baird’s AI Data-Center Growth Concerns

Nebius (NASDAQ:NBIS) Shares Soar 28% with Investors Responding to Q4 Revenue Growth

Investment Disclaimer